Pivotal bioVenture Partners Investment Advisor as of Dec. 31, 2025
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 24.5 | $63M | 1.4M | 46.14 | |
| Oculis Holding Ordinary Shares (OCS) | 17.7 | $46M | 2.3M | 19.97 | |
| Arcutis Biotherapeutics (ARQT) | 15.3 | $40M | 1.4M | 29.04 | |
| Evommune Com Shs (EVMN) | 12.8 | $33M | 1.9M | 17.12 | |
| Zenas Biopharma (ZBIO) | 8.3 | $22M | 592k | 36.31 | |
| Trevi Therapeutics (TRVI) | 6.1 | $16M | 1.3M | 12.52 | |
| Immunome (IMNM) | 6.1 | $16M | 733k | 21.48 | |
| Maplight Therapeutics (MPLT) | 4.2 | $11M | 611k | 17.57 | |
| Bioage Labs (BIOA) | 3.3 | $8.6M | 653k | 13.23 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.9 | $2.4M | 596k | 4.09 | |
| Rallybio Corp (RLYB) | 0.6 | $1.6M | 2.4M | 0.69 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.2 | $517k | 95k | 5.47 |
